BAY COUNTY, Fla. (WMBB)- Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 people died from colon cancer in the United States.

In 2024, the Food and Drug Administration (FDA) approved a blood test that can screen for colorectal cancer in people older than 45 years old at average risk for the disease. Some people may skip ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of removing tissue from the body. Traditional biopsies involve surgery, needles, ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...

A new test could be an option for the 40% of Americans over age 45 who are not up to date with screenings. The Food and Drug Administration provided final approval on Monday for a new colorectal ...

Originally from Northern California, Dr. Sam Asgarian came to love New Orleans while volunteering for cleanup post-Hurricane Katrina. His goal was always to become a primary care provider, wanting to ...

With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test on the road in hopes of tackling ...

The ctDNA test showed 79.2% sensitivity and 91.5% specificity for CRC detection in a diverse cohort. The study met primary end points but had limited sensitivity for advanced precancerous lesions.

Imagine checking for colon cancer with nothing more invasive than a routine blood draw -- no bowel prep, no sedation, and no awkward stool kit to mail. A new blood test called SHIELD is now available ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

The FDA has approved Guardant Health’s Shield blood test for colon cancer screening. The Shield blood test has been approved as a primary screening method for adults over 45 with an average risk for ...